It has been shown to trigger intrinsic apoptosis mainly by modulating the expressions of Bcl‐2 family proteins in different cancer cell lines of human origin including gastric cancer 73, 74, breast cancer 72, liver cancer 56, brain cancer 84 and prostate cancer 45. Here, BCL2 is linked to breast cancer.